HOME >> MEDICINE >> NEWS
Vitamin D targets thrombosis in cancer patients

A clinical trial of a biologically active metabolite of Vitamin D3 demonstrated an unanticipated reduction of thrombosis in cancer patients. Thrombosis is a serious complication in advanced cancers and affects between 15 and 20 per cent of all cancer patients.

Dr. Peter Venner, medical oncologist at the Alberta Cancer Board's Cross Cancer Institute, presented the finding today at the annual meeting of the American Society of Clinical Oncology (ASCO) in Atlanta, Georgia.

In a randomized trial involving 250 patients with advanced prostate cancer in 48 clinical sites, those receiving high-dose calcitriol (DN-101) along with Docetaxel experienced a significant reduction in both venous and arterial thromboses compared to patients receiving a placebo and Docetaxel. Calcitriol is a naturally occurring hormone and the biologically active form of Vitamin D.

While the clinical trial involved patients with advanced stages of prostate cancer, in vitro studies of myelogenous leukemia cells, monocytes and osteoblasts and observation in mice hold promise for improved safety in a wide range of cancers.

"This is a serendipitous outcome," says Dr. Venner. "It wasn't what we were looking for, but it offers an avenue of investigation that could result in a new class of anticoagulants, which could, in turn, significantly improve outcomes for cancer patients."

The study was primarily looking at the effects of DN-101 on PSA responses in patients with advanced prostate cancer and secondarily on survival rates. As part of the analysis of the data, its impact on reducing chemotherapy side effects was detected. The drug demonstrated a positive outcome on both survival and reduction of side effects. The effect on thrombosis that unexpectedly emerged from the study will be tested and confirmed in a recently activated phase III clinical trial.

The study was chaired by Dr. Tomasz M. Beer of Oregon Health and Science University and involved researc
'"/>

Contact: Lee Elliott
lee.elliott@cancerboard.ab.ca
780-409-5715
Alberta Cancer Board
2-Jun-2006


Page: 1 2

Related medicine news :

1. Vitamin D supplements may offer cheap and effective immune system boost against TB
2. Vitamin D supplements should be given to Asian children for two years from birth
3. Vitamin A deficiency linked to major intestinal surgery
4. Vitamin D and calcium supplements have varied effects on breast cancer risk
5. Vitamin C depletion correlates with lower body fat, not weight loss during short-term diet
6. Vitamin C and E supplements do not prevent pre-eclampsia in pregnant women at risk
7. Vitamin D inhibits progression of some prostate cancers
8. Vitamin D signals to prevent bone loss during osteoporosis
9. Vitamin D supplementation during pregnancy could reduce osteoporosis in children
10. Vitamin D can play role in lung health
11. Vitamin D status appears more important than high calcium intake for maintaining calcium metabolism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2019)... ... ... LEAD Hospitality Group is preparing to participate in the 36th annual Magnolia Run & ... to take place August 17, 2019 and will kick off at The Green Space ... Buildings. LEAD Hospitality Group will be attending with their running team, “Spring for Seizures.” ...
(Date:7/17/2019)... ... July 17, 2019 , ... ... that is capable of treating up to eight body areas simultaneously. Dr. Dennis ... muscle toning much faster and easier than previous muscle toning devices or conventional exercise. ...
(Date:7/17/2019)... ... 17, 2019 , ... Becker's Healthcare is pleased to recognize ... men and women included on this list lead organizations regularly recognized for patient ... well as the construction of satellite clinics and strategic partnerships with local healthcare ...
(Date:7/17/2019)... DIEGO (PRWEB) , ... July 17, 2019 , ... People ... become parents. Every Intended Parents’ story differs , but, in addition to creating ... Surrogate. , Across the globe, more and more Intended Parents are electing to have ...
(Date:7/17/2019)... ... ... Dr. Jonathan Zaidan, MD, FACOG, President of Women’s Excellence discusses a new weight loss ... on Wednesday, July 17ths at 7pm. The show podcast will be available online ... the challenges that women face when it comes to weight loss and any health ...
Breaking Medicine News(10 mins):
(Date:7/19/2019)... ... July 19, 2019 , ... The new ... a novel non-invasive transdermal (over-the-skin) technology, which is the leader in the field ... the clinical evidence obtained by Circularity over the past six years. The clinical ...
(Date:7/19/2019)... ... July 19, 2019 , ... The San Francisco employment ... class action lawsuit against Hospital Couriers Nevada, LLC, for allegedly failing to provide ... and rest periods. The class action also alleges that Hospital Couriers Nevada, LLC, ...
(Date:7/18/2019)... ... July 18, 2019 , ... ... pharmaceutical companies reach meeting regulatory guidelines and achieve optimum TMF Health. , ... TMF Health, Phlexglobal will host two Lunch and Learn events to present information ...
Breaking Medicine Technology:
Cached News: